Search results

  1. D

    Suppressed immune and metabolic responses to intestinal damage-associated microbial translocation in [ME/CFS], 2023, Uhde, Vernon et al.

    There is a lot going on in this paper. Tthe authors performed metabolomics pre/post exercise in addition to more specific analysis of gut antigens. While things certainly seemed different in the GI, I'm not sure what exactly they would tell us, and I'm not sure how meaningful some of the...
  2. D

    Research news from Bhupesh Prusty

    One question I had at the start, was there a need to "get this out there" on twitter and naturally generate social media hype. I think the answer to that is pretty uniformly "no" and in retrospect does not benefit the me/cfs community. I think that colors the situation quite badly.
  3. D

    Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls, 2023, Giloteaux et al

    Serpina5 came up in a multi-omics paper on long covid. And here in a genetic evaluation in me/cfs.
  4. D

    Neural dysregulation in post-COVID fatigue 2023 Baker et al

    Interesting paper, I've read about half of it. The authors are from Newcastle University, and aim to test if any of a slew of neurological tests can indicate which of 5 potential hypothesized pathologies of fatigue would apply to Long Covid patients (6-26 weeks after infection, average fatigue...
  5. D

    USA: Cleveland Clinic

    My experience has been that a clinician will start with the bio-social and leave out the psychology at first, at least directly, and then add that element in. In practice, this ends up sounding it does here, me/cfs as a lifestyle illness. Which is offensive by itself.
  6. D

    USA: Cleveland Clinic

    Just because it's a top clinic doesn't mean their understanding of me/cfs is superior. (e.g. mayo clinic) Pretty much every point you mentioned is a red flag. Mayo also told their patients similar recovery rates. ME/CFS isn't caused by lowered adrenaline and noradrenaline. Metaphrines? All I get...
  7. D

    Long Covid in the media and social media 2022

    Thanks for listening. I saw it and kind of avoided it. Starting with a personal, BPS anecdote is exactly the kind of thing that will stick in people's mind and be a deciding take on the condition. I was a bit thinking that's the underlying take the Economist and it's subsidiaries would have. I...
  8. D

    Astellas' Bocidelpar - drug to restore mitochondrial function

    Maybe some side-effects popped up and they couldn't justify moving forward. It's use in me/cfs seemed hugely speculative, I'm not sure what the expectation are/were.
  9. D

    OMF: Muscle Biopsy and Plasma Study into Post-Exertional Malaise, David Systrom, 2022

    As someone who has not followed Systrom's work closely, how accurate is the statement from OMF: My understanding, which may be incorrect, was that the 2-day CPET results were an oddity in me/cfs, but maybe not unique to it. I was unaware of the claim that 2-day CPET can identify PEM or...
  10. D

    Suppose you have €5-10 million for ME/CFS research, what would you spend it on?

    I have mentioned before biopsy studies would be interesting to me, and I was optimistic for the Harvard OMF's study before Tompkins passing. As he was uniquely qualified I don't know what will happen there. There have been quite a few studies imaging the brain, and many of them have been...
  11. D

    Long Covid in the media and social media 2022

    Well, surely he had no preconceived notions going in! His response to legitimate criticism of his article will undoubtedly be to claim he is under-attack and being harassed. We should have the NIH apology for that made up claim by a BPS researchers show up where the Newspaper is made up...
  12. D

    Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism 2022, Patel et al

    This paper is interesting, the findings of increase in ANG-1 and P-SEL are large in the long covid cohort vs others with no overlap. I don't know how meaningful grouping 14 factors together is, but AUC=1 is quite good, no? I don't know how frequently the ANG-1/P-SEL factors are tested for, but...
  13. D

    Circadian skin temperature rhythm and dysautonomia in [ME/CFS]: ... endothelin-1 in vascular dysregulation, 2023, Cambras et al

    I was only able to get through the first half of the methods paper, but this at least looks like more thorough and earnest attempt from a group I don't know about (in spain). Criteria was ICC from a single referral clinic in Barcelona. One important note is the authors say none of the controls...
  14. D

    Dr Ron Davis - Updates on ME/CFS research - September 2019 onwards

    Bateman is coauthor in some of the Cortene studies, I don't know the extent of the relationship. I believe she supplied some patients so that may be where some of this stress response narrative is coming from. The diagram does indeed seem quite silly, I think you could create about 100 ones that...
  15. D

    USA: National Institutes of Health (NIH) intramural Long Covid study with Avi Nath

    Still waiting on anything published, other than a PEM survey, on the me/cfs study that started before covid-19 was around. Is it a Nath thing or NIH thing? What a disaster. So they just halted it to slowly churn through post-covid and throw steriods and IVIG at 12 patients. I don't know if I...
  16. D

    Exposure to phenytoin associates with a lower risk of post-COVID cognitive deficits: a cohort study, 2022, Taquet and Harrison

    Interesting. It looks like a good attempt from the authors, but I didn't read the paper in depth; there is a helpful infographic following the abstract for anyone who can't read the entire paper. Fatigue is also analyzed as an outcome in the supplementary material but I wasn't sure how to read...
  17. D

    A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome, 2022, Kovarik et al

    Iirc Ron Davis said he found higher omega3s in me/cfs patients but postulated it was due to supplementation. Think it was in a video.
  18. D

    Neurovascular injury with complement activation and inflammation in COVID-19, 2022, Lee ... Nath et al

    I remember this from when they started because of how atypical the cohort was, and therefore a stretch to connect it to me/cfs. This is@Forbin 's quoting Nath during an NIH call.
  19. D

    Request from Robert Phair re Brainstem connectome diagram

    There is this paper by the Griffith University group that may be relevant to "Intra-brainstem connectivity is impaired in Chronic Fatigue Syndrome", but it uses the Fukuda criteria. These papers might ahve some useful figures for you, it's beyond my knowledge base tbh...
Back
Top Bottom